| scholarly article | Q13442814 |
| P2093 | author name string | Richard Grose | |
| Athina-Myrto Chioni | |||
| P2860 | cites work | Cellular signaling by fibroblast growth factor receptors | Q24301087 |
| A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes | Q24315666 | ||
| Fibroblast growth factors | Q24542507 | ||
| Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family | Q24676527 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer | Q27851554 | ||
| 90-kDa ribosomal S6 kinase is a direct target for the nuclear fibroblast growth factor receptor 1 (FGFR1): role in FGFR1 signaling | Q28259259 | ||
| Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2 | Q28283279 | ||
| Cloning of cDNA for the glutamate-binding subunit of an NMDA receptor complex | Q28574514 | ||
| Spatial and temporal patterns of ERK signaling during mouse embryogenesis | Q28594004 | ||
| Notch signalling: a simple pathway becomes complex | Q29555851 | ||
| Fibroblast growth factor signalling: from development to cancer | Q29616827 | ||
| A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis | Q29617776 | ||
| Structural characterization of the circulating soluble FGF receptors reveals multiple isoforms generated by secretion and ectodomain shedding | Q30651053 | ||
| Granzyme B proteolyzes receptors important to proliferation and survival, tipping the balance toward apoptosis | Q33247896 | ||
| Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. | Q33414759 | ||
| Regulation of endocytosis, nuclear translocation, and signaling of fibroblast growth factor receptor 1 by E-cadherin | Q33564095 | ||
| Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain. | Q33889677 | ||
| Nuclear trafficking of the epidermal growth factor receptor family membrane proteins | Q33998459 | ||
| Extracellular matrix remodeling by human granzyme B via cleavage of vitronectin, fibronectin, and laminin. | Q34412822 | ||
| Mechanisms underlying differential responses to FGF signaling | Q34415005 | ||
| Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes | Q34493133 | ||
| Novel nuclear signaling pathway mediates activation of fibroblast growth factor-2 gene by type 1 and type 2 angiotensin II receptors | Q34983958 | ||
| Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo | Q35558255 | ||
| FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis | Q35794378 | ||
| Nuclear Translocation of fibroblast growth factor (FGF) receptors in response to FGF-2. | Q36236991 | ||
| Nuclear translocation of cell-surface receptors: lessons from fibroblast growth factor | Q36247430 | ||
| Importin beta-mediated nuclear import of fibroblast growth factor receptor: role in cell proliferation | Q36381086 | ||
| Expression of endogenous granzyme B in a subset of human primary breast carcinomas | Q36670835 | ||
| Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation. | Q36860354 | ||
| Integrative nuclear signaling in cell development--a role for FGF receptor-1. | Q37004768 | ||
| Fibroblast growth factor receptor-1 (FGFR1) nuclear dynamics reveal a novel mechanism in transcription control | Q37175392 | ||
| Negative regulation of fibroblast growth factor 10 (FGF-10) by polyoma enhancer activator 3 (PEA3). | Q37215604 | ||
| Nuclear expression of epidermal growth factor receptor is a novel prognostic value in patients with ovarian cancer | Q37282661 | ||
| Trafficking of receptor tyrosine kinases to the nucleus | Q37308472 | ||
| Organotypic modelling as a means of investigating epithelial-stromal interactions during tumourigenesis | Q37348888 | ||
| Nuclear accumulation of fibroblast growth factor receptors is regulated by multiple signals in adrenal medullary cells | Q37382062 | ||
| Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. | Q37486259 | ||
| Internalization of fibroblast growth factor receptor is inhibited by a point mutation at tyrosine 766. | Q38307028 | ||
| High expression of stratifin is a universal abnormality during the course of malignant progression of early-stage lung adenocarcinoma | Q39612023 | ||
| Vesicle transmembrane potential is required for translocation to the cytosol of externally added FGF-1. | Q39648002 | ||
| Development of a quantitative method to analyse tumour cell invasion in organotypic culture | Q39706819 | ||
| Granzyme B is expressed in urothelial carcinoma and promotes cancer cell invasion. | Q39760255 | ||
| Protein kinase A and regulation of neonatal Nav1.5 expression in human breast cancer cells: activity-dependent positive feedback and cellular migration | Q39769255 | ||
| Nuclear EGFR contributes to acquired resistance to cetuximab | Q39812008 | ||
| FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas | Q40205335 | ||
| A novel polyclonal antibody specific for the Na(v)1.5 voltage-gated Na(+) channel 'neonatal' splice form | Q40383358 | ||
| Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway | Q40410769 | ||
| Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer. | Q40467153 | ||
| Nuclear trafficking of FGFR1: a role for the transmembrane domain | Q40662478 | ||
| A nuclear form of the heparin-binding epidermal growth factor-like growth factor precursor is a feature of aggressive transitional cell carcinoma. | Q40675300 | ||
| Nuclear localization of EGF receptor and its potential new role as a transcription factor | Q40782527 | ||
| Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHalpha1) death signal | Q41059135 | ||
| Nuclear localization of p185neu tyrosine kinase and its association with transcriptional transactivation | Q41441273 | ||
| Reaction of serine proteases with substituted isocoumarins: discovery of 3,4-dichloroisocoumarin, a new general mechanism based serine protease inhibitor | Q42225238 | ||
| Dual mode of signal transduction by externally added acidic fibroblast growth factor | Q42800548 | ||
| Ligand dependent and independent internalization and nuclear translocation of fibroblast growth factor (FGF) receptor 1. | Q42825244 | ||
| Integrative nuclear FGFR1 signaling (INFS) pathway mediates activation of the tyrosine hydroxylase gene by angiotensin II, depolarization and protein kinase C. | Q44028783 | ||
| The serine protease marapsin is expressed in stratified squamous epithelia and is up-regulated in the hyperproliferative epidermis of psoriasis and regenerating wounds | Q46140598 | ||
| Control of CREB-binding protein signaling by nuclear fibroblast growth factor receptor-1: a novel mechanism of gene regulation | Q46522283 | ||
| Elements controlling the expression and induction of the skin hyperproliferation-associated keratin K6. | Q48070735 | ||
| Nuclear localization of functional FGF receptor 1 in human astrocytes suggests a novel mechanism for growth factor action | Q71339849 | ||
| In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals | Q71808981 | ||
| Altered intracellular localization of fibroblast growth factor receptor 3 in human breast cancer | Q73820422 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| P1104 | number of pages | 17 | |
| P304 | page(s) | 801-817 | |
| P577 | publication date | 2012-06-04 | |
| P1433 | published in | Journal of Cell Biology | Q1524550 |
| P1476 | title | FGFR1 cleavage and nuclear translocation regulates breast cancer cell behavior | |
| P478 | volume | 197 |
| Q38287257 | "Nuclear FGF receptor-1 and CREB binding protein: an integrative signaling module". |
| Q52785661 | 3D Organotypic Culture Model to Study Components of ERK Signaling. |
| Q93064606 | A gain-of-functional screen identifies the Hippo pathway as a central mediator of receptor tyrosine kinases during tumorigenesis |
| Q37600446 | Activation of the FGFR-STAT3 pathway in breast cancer cells induces a hyaluronan-rich microenvironment that licenses tumor formation. |
| Q38656592 | Association of FGFR1 with ERαmaintains ligand-independent ER transcription and mediates resistance to estrogen deprivation in ER+ breast cancer. |
| Q93145965 | Catalytically inactive receptor tyrosine kinase PTK7 activates FGFR1 independent of FGF |
| Q34077207 | Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells |
| Q38475854 | Coalition of Nuclear Receptors in the Nervous System. |
| Q39017298 | Common developmental genome deprogramming in schizophrenia - Role of Integrative Nuclear FGFR1 Signaling (INFS). |
| Q58566489 | Emerging Roles of Fibroblast Growth Factor 10 in Cancer |
| Q35816309 | Engineering targeted chromosomal amplifications in human breast epithelial cells |
| Q38905296 | EphB4 localises to the nucleus of prostate cancer cells. |
| Q28078898 | Evidence-Based Theory for Integrated Genome Regulation of Ontogeny--An Unprecedented Role of Nuclear FGFR1 Signaling |
| Q90133145 | Expression of FGFR1-4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor Sensitivity |
| Q98906651 | FGF/FGFR signaling in health and disease |
| Q33935206 | FGF10: Type III Epithelial Mesenchymal Transition and Invasion in Breast Cancer Cell Lines |
| Q38766035 | FGFR-targeted therapeutics for the treatment of breast cancer. |
| Q52714441 | FGFR1 fusion kinase regulation of MYC expression drives development of stem cell leukemia/lymphoma syndrome. |
| Q38644648 | FGFR1 is critical for the anti-endothelial mesenchymal transition effect of N-acetyl-seryl-aspartyl-lysyl-proline via induction of the MAP4K4 pathway |
| Q37620612 | Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer |
| Q38959812 | Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapy. |
| Q37716969 | Fibroblast growth factor signaling regulates the expansion of A6-expressing hepatocytes in association with AKT-dependent β-catenin activation |
| Q39282670 | Fibroblast growth factor-mediated crosstalk in cancer etiology and treatment. |
| Q28554418 | Genome Analysis of Osteosarcoma Progression Samples Identifies FGFR1 Overexpression as a Potential Treatment Target and CHM as a Candidate Tumor Suppressor Gene |
| Q35552948 | Global Developmental Gene Programing Involves a Nuclear Form of Fibroblast Growth Factor Receptor-1 (FGFR1). |
| Q35672982 | HPV16 Down-Regulates the Insulin-Like Growth Factor Binding Protein 2 to Promote Epithelial Invasion in Organotypic Cultures |
| Q33569831 | Improved HSC reconstitution and protection from inflammatory stress and chemotherapy in mice lacking granzyme B. |
| Q40463360 | Integrative meta-modeling identifies endocytic vesicles, late endosome and the nucleus as the cellular compartments primarily directing RTK signaling. |
| Q37396056 | Interactions between FGFR2 and RSK2-implications for breast cancer prognosis. |
| Q37717525 | Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function |
| Q64092327 | Membrane-Associated, Not Cytoplasmic or Nuclear, FGFR1 Induces Neuronal Differentiation |
| Q34851892 | NGF-induced cell differentiation and gene activation is mediated by integrative nuclear FGFR1 signaling (INFS). |
| Q37710812 | Nuclear translocation of FGFR1 and FGF2 in pancreatic stellate cells facilitates pancreatic cancer cell invasion |
| Q53705802 | PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer. |
| Q33886981 | Pancreatic cancer organotypics: High throughput, preclinical models for pharmacological agent evaluation |
| Q34724831 | Phosphorylation and nuclear translocation of integrin β4 induced by a chemical small molecule contribute to apoptosis in vascular endothelial cells |
| Q36113481 | Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases |
| Q26830216 | Receptor tyrosine kinases in the nucleus |
| Q90706409 | Targeting Cellular Trafficking of Fibroblast Growth Factor Receptors as a Strategy for Selective Cancer Treatment |
| Q38212165 | Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall? |
| Q34495216 | The FGF/FGFR axis as a therapeutic target in breast cancer |
| Q91783996 | The FGFR1 V561M Gatekeeper Mutation Drives AZD4547 Resistance through STAT3 Activation and EMT |
| Q37235526 | The FGFR1 inhibitor PD173074 induces mesenchymal-epithelial transition through the transcription factor AP-1. |
| Q34467171 | The Fibroblast Growth Factor signaling pathway |
| Q38208062 | The ins and outs of fibroblast growth factor receptor signalling. |
| Q36471425 | Treatment of Triple-Negative Breast Cancer with TORC1/2 Inhibitors Sustains a Drug-Resistant and Notch-Dependent Cancer Stem Cell Population |
| Q37159039 | Tyrosine kinase receptors as molecular targets in pheochromocytomas and paragangliomas. |
Search more.